APUS · Apimeds Pharmaceuticals US, Inc. · Fails to Deliver
$2.71
-0.03 (-0.92%)
At close · Nov 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date these condensed consolidated financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$4.08M
Shares
1.51M
Volume · Nov 6
16.69K
Avg daily vol (3M)
3.7M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-09-30 | 8,068 | $5.02 | $40,501 |
| 2026-09-29 | 41,507 | $6.39 | $265,230 |
| 2026-09-28 | 200,263 | $7.25 | $1,451,907 |
| 2026-09-25 | 583,360 | $4.92 | $2,870,131 |
| 2026-09-24 | 691 | $2.29 | $1,582 |
| 2026-09-23 | 2,744 | $1.85 | $5,076 |
| 2026-09-22 | 5,159 | $1.67 | $8,616 |
| 2026-09-21 | 162 | $1.77 | $287 |
| 2026-09-18 | 1,137 | $1.67 | $1,899 |
| 2026-09-10 | 1,153 | $2.29 | $2,640 |
| 2026-09-09 | 1 | $2.30 | $2 |
| 2026-09-08 | 39 | $2.42 | $94 |
| 2026-09-04 | 3 | $2.51 | $8 |
| 2026-09-03 | 2,856 | $2.63 | $7,511 |
| 2026-08-28 | 2,965 | $3.95 | $11,712 |
| 2026-08-27 | 1 | $4.60 | $5 |
| 2026-08-26 | 252 | $4.97 | $1,252 |
| 2026-08-25 | 251 | $4.75 | $1,192 |
| 2026-08-19 | 10,208 | $4.00 | $40,832 |
| 2026-08-18 | 13,032 | $4.28 | $55,777 |
Showing 1–20 of 20 settlements